(Q35789503)

10 August 2017

1 reference

title

Lipidfiltration--safe and effective methodology to perform lipid-apheresis (English)

1 reference

10 August 2017

Reinhard Klingel

1

1 reference

10 August 2017

Patrick Mausfeld

series ordinal

2

1 reference

10 August 2017

Cordula Fassbender

series ordinal

3

1 reference

10 August 2017

Britta Goehlen

series ordinal

4

1 reference

10 August 2017

publication date

1 June 2004

1 reference

Transfusion and Apheresis Science

10 August 2017

published in

1 reference

10 August 2017

volume

30

1 reference

10 August 2017

issue

3

1 reference

10 August 2017

page(s)

245-254

1 reference

Familial Hypercholesterolaemia Regression Study: a randomised trial of low-density-lipoprotein apheresis.

10 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2004.01.008

Effects of combined low-density lipoprotein apheresis and aggressive statin therapy on coronary calcified plaque as measured by computed tomography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2004.01.008

LDL-Apheresis Atherosclerosis Regression Study (LAARS). Effect of aggressive versus conventional lipid lowering treatment on coronary atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2004.01.008

Long-term efficacy of low-density lipoprotein apheresis on coronary heart disease in familial hypercholesterolemia. Hokuriku-FH-LDL-Apheresis Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2004.01.008

Intravascular ultrasound evaluation of coronary plaque regression by low density lipoprotein-apheresis in familial hypercholesterolemia: the Low Density Lipoprotein-Apheresis Coronary Morphology and Reserve Trial (LACMART).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2004.01.008

The HELP-LDL-apheresis multicentre study, an angiographically assessed trial on the role of LDL-apheresis in the secondary prevention of coronary heart disease. II. Final evaluation of the effect of regular treatment on LDL-cholesterol plasma concen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2004.01.008

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2004.01.008

First steps toward the establishment of a German low-density lipoprotein-apheresis registry: recommendations for the indication and for quality management.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2004.01.008

LDL hemoperfusion--a new procedure for LDL apheresis: biocompatibility results from a first pilot study in hypercholesterolemic atherosclerosis patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2004.01.008

Intraindividual comparison of two extracorporeal LDL apheresis methods: lipidfiltration and HELP.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2004.01.008

Prospective randomised cross-over comparison of three LDL-apheresis systems in statin pretreated patients with familial hypercholesterolaemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2004.01.008

Low-density lipoprotein removal methods by membranes and future perspectives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2004.01.008

An effective LDL removal filter for the treatment of hyperlipidemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2004.01.008

Evaluation of double filtration plasmapheresis, thermofiltration, and low-density lipoprotein adsorptive methods by crossover test in the treatment of familial hypercholesterolemia patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2004.01.008

Apheretic treatment of severe familial hypercholesterolemia: comparison of dextran sulfate cellulose and double membrane filtration methods for low density lipoprotein removal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2004.01.008

Low density lipoprotein apheresis by membrane differential filtration (cascade filtration)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2004.01.008

Efficacy of different low-density lipoprotein apheresis methods

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2004.01.008

Consistent lowering of clotting factors for the treatment of acute cardiovascular syndromes and hypercoagulability: a different pathophysiological approach

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2004.01.008

Double filtration plasmapheresis maintains normal adhesion molecule levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2004.01.008

Plasma viscosity increase with progression of peripheral arterial atherosclerotic disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2004.01.008

Hemorrheologic abnormalities in defined primary dyslipoproteinemias with both high and low atherosclerotic risks

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2004.01.008

The possible role of hemorheology in atherothrombogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2004.01.008

Single LDL apheresis improves endothelium-dependent vasodilatation in hypercholesterolemic humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2004.01.008

Low-density lipoprotein (LDL) oxidizability before and after LDL apheresis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2004.01.008

Oxidizability of atherogenic low-density lipoprotein subspecies in severe familial hypercholesterolemia: impact of long-term low-density lipoprotein apheresis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2004.01.008

Cost and health implications of cholesterol lowering

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2004.01.008

Lowering LDL cholesterol: questions from recent meta-analyses and subset analyses of clinical trial DataIssues from the Interdisciplinary Council on Reducing the Risk for Coronary Heart Disease, ninth Council meeting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2004.01.008

Long-term effect of low-density lipoprotein apheresis on plasma lipoproteins and coronary heart disease in native vessels and coronary bypass in severe heterozygous familial hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2004.01.008

Therapeutic efficiency of lipoprotein(a) reduction by low-density lipoprotein immunoapheresis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2004.01.008

Membrane differential filtration is safe and effective for the long-term treatment of Refsum syndrome--an update of treatment modalities and pathophysiological cognition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2004.01.008

Lipapheresis: an immunoglobulin-sparing treatment for Refsum's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2004.01.008

Differential indication of lipoprotein apheresis during pregnancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2004.01.008

Effect of HELP-LDL-apheresis on outcomes in patients with advanced coronary atherosclerosis and severe hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2004.01.008

Three low density lipoprotein apheresis techniques in treatment of patients with familial hypercholesterolemia: a long-term evaluation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2004.01.008

Prospective cross-over comparisons of three low-density lipoprotein (LDL)-apheresis methods in patients with familial hypercholesterolaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2004.01.008

Long-term experience with extracorporeal low-density lipoprotein cholesterol removal by dextran sulfate cellulose adsorption

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2004.01.008

In vitro evaluation of dextran sulfate cellulose beads for whole blood infusion low-density lipoprotein-hemoperfusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2004.01.008

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.TRANSCI.2004.01.008

1 reference

10 August 2017

1 reference